December 21, 2018 Upcoming events – Phase III readouts loom for Urogen and Mediwound Urogen is gearing up to release the results of a pivotal trial of its lead asset – and so is Mediwound.
July 05, 2017 Biotech floats come back with a vengeance The biotech IPO market records its first billion dollar quarter in two years as demand for new issues recovers.
